Financial Statements — GENB
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 135.36 | 160.57 |
| Short-term Investments | 322.06 | 356.07 |
| Total Current Assets | 470.25 | 535.39 |
| Property, Plant & Equipment | 27.31 | 27.84 |
| Total Non-current Assets* | 91.44 | 90.35 |
| Total Assets | 561.69 | 625.74 |
| Accounts Payable | 5.65 | 7.62 |
| Total Current Liabilities | 56.64 | 58.39 |
| Total Non-current Liabilities* | 49.01 | 52.55 |
| Total Liabilities | 105.65 | 110.94 |
| Retained Earnings | (804.99) | (737.74) |
| Total Stockholder Equity | 456.05 | 514.80 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Total Revenue | 6.31 | 7.22 |
| Research & Development | 64.33 | 57.81 |
| Selling, General & Admin | 13.60 | 13.52 |
| Total Operating Expenses | 77.93 | 71.34 |
| Operating Income | (71.61) | (64.11) |
| Pretax Income | (67.20) | (61.69) |
| Tax Provision | 0.05 | 0.03 |
| Net Income | (67.25) | (61.45) |
| Basic EPS | (0.52) | (1.07) |
| Diluted EPS | (0.52) | (1.07) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (57.94) | (80.39) |
| Capital Expenditures | 0.93 | 3.78 |
| Free Cash Flow* | (58.88) | (84.17) |
| Investing Cash Flow | 33.31 | (259.93) |
| Financing Cash Flow | (0.58) | 378.89 |
* Derived from reported values
